Engaging partners in the breastfeeding journey
The most important support person for women to succeed in their ambition to breastfeed is the new mother's partner. The partner also needs to be included through more support from…
Role of ‘hunger hormone’ receptor in obesity-realted chronic inflammation
A team of scientists has made an important discovery that could lead to a novel treatment for obesity and obesity-associated diseases or conditions.
£1.9M funding supports research into drivers of health disparities and associated infectious disease burden
Dr Rosalind Eggo, an Associate Professor of Infectious Disease Modelling at the London School of Hygiene & Tropical Medicine (LSHTM), has been awarded over £1.9 million funding to lead research…
Annexin-A1 targeted therapy beats several cancers
A new study published in Nature's cancer journal Oncogene highlights the effectiveness of MDX-124, the first therapeutic drug to target annexin-A1, a protein which is overexpressed in several cancer types…
Women using drugs and alcohol can feel stigmatized when seeking treatment
Women using drugs and alcohol can feel stigmatized and shamed when seeking support from professional services, a new study has found.
COST Action bridges the gap in cancer immunotherapy research
Cancer is still a leading cause of death worldwide. Globally, there were an estimated 20 million new cases of cancer and 10 million deaths.
RecA protein skips “unwinding” step in DNA repair
Researchers from Tokyo Metropolitan University have been studying DNA repair by homologous recombination, where the RecA protein repairs breaks in double-stranded DNA by incorporating a dangling single-strand end into intact…
AI scores breakthrough in anemia treatment with novel PHD inhibitor
Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine ("InSilico"), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal focusing on critical studies about molecular structure…
Insilico Medicine leverages AI to identify promising new target for breast and gynecological cancers
Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven drug discovery company, recently published an early research that it has identified MYT1 as a promising new therapeutic target for breast…
COVID-19-associated blood plasma inflammatory factors do not affect blood-brain barrier, study shows
It is now well documented that the coronavirus outbreak triggered a global health crisis. In this study, researchers wanted to know whether blood-brain barrier impairment contributed to the development of…